Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
48%
Total
Publications
222
Total Open
Publications
106
Total
Citations
6.4K
Open Access
Percentage
48%
Total
Publications
222
Total Open
Publications
106
Total
Citations
6.4K
Breakdown
Publisher Open
16%
Both
26%
Other Platform Open
6%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
25
Hybrid 35%
33
No Guarantees 38%
35
Other Platform Open
Domain 86%
61
Institution 27%
19
Public 14%
10
Preprint 8%
6
Other Internet 7%
5
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 61 |
Europe PMC | Domain | 42 |
DOI | Other Internet | 20 |
Figshare | Public | 12 |
whiterose.ac.uk OAI-PMH Repository | Institution | 11 |
Research Square | Preprint | 8 |
Semantic Scholar | Public | 5 |
University of Surrey - Surrey Open Research repository | Institution | 4 |
University College London - UCL Discovery | Institution | 4 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 3 |